. 2024 Nov 12;16(11):e73546. doi: 10.7759/cureus.73546

Table 3. Impact of the COVID-19 pandemic on takotsubo syndrome.

^P: Pearson chi-square test; ^L: logistic regression; ^Ln: linear regression.

P-value < 0.05 indicates statistical significance.

	Pre-COVID-19 pandemic (2017-2018)	COVID-19 pandemic (2020-2021)	95% confidence interval	P-value
Mortality rate in takotsubo patients (%)	6.04	8.67	-	<0.001^P
Odds of mortality in takotsubo patients
-Unadjusted	1	1.47	1.35 - 1.61	<0.001^L
-Adjusted with COVID-19 status	1	1.28	1.17 - 1.41	<0.001^L
-Adjusted with multiple potential confounders and covariates	1	1.28	1.17 - 1.41	<0.001^L
Length of stay (LOS) of takotsubo admissions
-Mean (days) (95% CI)	6.9 (6.7-7.1)	7.2 (7.1-7.5)	-	-
-Day increase in LOS	0	0.43	0.15 - 0.70	0.003^Ln
-Adjusted with COVID-19 status (days)	0	0.12	-0.16 - 0.39	0.404^Ln
-Adjusted with multiple potential confounders covariates (days)	0	-0.004	-0.24 - 0.23	0.975^Ln